TCF4 and cancer: The results showed that henryin strongly inhibited the binding of TCF4 to β-catenin in a dose-dependent manner in SW480 cells but not its analogs enmenol and minheryin C (Figure 5D, 5F), which is consistent with the inhibitory activities on the Wnt signaling and the cancer cell growth of the compounds.